Calcium in PDB 1biw: Design and Synthesis of Conformationally-Constrained Mmp Inhibitors
Enzymatic activity of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors
All present enzymatic activity of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors:
3.4.24.17;
Protein crystallography data
The structure of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors, PDB code: 1biw
was solved by
M.G.Natchus,
M.Cheng,
C.T.Wahl,
S.Pikul,
N.G.Almstead,
R.S.Bradley,
Y.O.Taiwo,
G.E.Mieling,
C.M.Dunaway,
C.E.Snider,
J.M.Mciver,
B.L.Barnett,
S.J.Mcphail,
M.B.Anastasio,
B.De,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
8.00 /
2.50
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
38.060,
77.280,
106.400,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
24.7 /
27.5
|
Other elements in 1biw:
The structure of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Design and Synthesis of Conformationally-Constrained Mmp Inhibitors
(pdb code 1biw). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 6 binding sites of Calcium where determined in the
Design and Synthesis of Conformationally-Constrained Mmp Inhibitors, PDB code: 1biw:
Jump to Calcium binding site number:
1;
2;
3;
4;
5;
6;
Calcium binding site 1 out
of 6 in 1biw
Go back to
Calcium Binding Sites List in 1biw
Calcium binding site 1 out
of 6 in the Design and Synthesis of Conformationally-Constrained Mmp Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca303
b:2.0
occ:1.00
|
O
|
A:GLY159
|
2.3
|
7.2
|
1.0
|
OE2
|
A:GLU184
|
2.3
|
1.5
|
1.0
|
OD2
|
A:ASP181
|
2.3
|
14.9
|
1.0
|
O
|
A:VAL163
|
2.3
|
4.1
|
1.0
|
OD1
|
A:ASP158
|
2.3
|
9.7
|
1.0
|
O
|
A:GLY161
|
2.4
|
3.9
|
1.0
|
CG
|
A:ASP181
|
2.8
|
12.7
|
1.0
|
OD1
|
A:ASP181
|
3.2
|
16.6
|
1.0
|
C
|
A:VAL163
|
3.4
|
5.5
|
1.0
|
C
|
A:GLY159
|
3.5
|
4.8
|
1.0
|
CD
|
A:GLU184
|
3.5
|
2.6
|
1.0
|
C
|
A:GLY161
|
3.5
|
3.4
|
1.0
|
CG
|
A:ASP158
|
3.5
|
8.2
|
1.0
|
CB
|
A:ASP181
|
3.7
|
9.0
|
1.0
|
N
|
A:GLY161
|
3.9
|
4.5
|
1.0
|
C
|
A:PRO160
|
4.1
|
5.8
|
1.0
|
N
|
A:GLY159
|
4.1
|
3.4
|
1.0
|
OD2
|
A:ASP158
|
4.2
|
12.5
|
1.0
|
CA
|
A:GLY161
|
4.2
|
1.5
|
1.0
|
CA
|
A:VAL163
|
4.2
|
4.2
|
1.0
|
OE1
|
A:GLU184
|
4.3
|
4.2
|
1.0
|
N
|
A:VAL163
|
4.3
|
5.0
|
1.0
|
N
|
A:ASP158
|
4.3
|
4.8
|
1.0
|
N
|
A:PRO160
|
4.4
|
5.1
|
1.0
|
CA
|
A:GLY159
|
4.4
|
3.8
|
1.0
|
N
|
A:LEU164
|
4.4
|
5.8
|
1.0
|
CG
|
A:GLU184
|
4.4
|
1.5
|
1.0
|
CA
|
A:PRO160
|
4.4
|
4.2
|
1.0
|
C
|
A:ASP158
|
4.5
|
5.4
|
1.0
|
O
|
A:PRO160
|
4.5
|
11.3
|
1.0
|
CA
|
A:LEU164
|
4.5
|
3.0
|
1.0
|
C
|
A:ASN162
|
4.6
|
6.6
|
1.0
|
CA
|
A:ASP158
|
4.6
|
6.5
|
1.0
|
CB
|
A:ASP158
|
4.7
|
1.5
|
1.0
|
N
|
A:ASN162
|
4.7
|
5.6
|
1.0
|
CB
|
A:VAL163
|
4.9
|
2.8
|
1.0
|
O
|
A:ASN162
|
4.9
|
6.9
|
1.0
|
|
Calcium binding site 2 out
of 6 in 1biw
Go back to
Calcium Binding Sites List in 1biw
Calcium binding site 2 out
of 6 in the Design and Synthesis of Conformationally-Constrained Mmp Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca304
b:7.2
occ:1.00
|
O
|
A:ASP182
|
2.3
|
6.6
|
1.0
|
O
|
A:GLU184
|
2.3
|
1.8
|
1.0
|
OD2
|
A:ASP107
|
2.3
|
9.6
|
1.0
|
OD1
|
A:ASP107
|
2.3
|
2.1
|
1.0
|
OD1
|
A:ASP182
|
2.4
|
5.0
|
1.0
|
CG
|
A:ASP107
|
2.7
|
5.0
|
1.0
|
O
|
A:HOH315
|
2.9
|
30.8
|
1.0
|
O
|
B:HOH808
|
3.1
|
12.8
|
1.0
|
C
|
A:ASP182
|
3.4
|
4.8
|
1.0
|
C
|
A:GLU184
|
3.5
|
1.5
|
1.0
|
CG
|
A:ASP182
|
3.5
|
1.7
|
1.0
|
CA
|
A:ASP182
|
4.1
|
2.1
|
1.0
|
CA
|
A:GLN185
|
4.3
|
3.6
|
1.0
|
CB
|
A:ASP182
|
4.3
|
1.5
|
1.0
|
CB
|
A:ASP107
|
4.3
|
1.5
|
1.0
|
N
|
A:GLN185
|
4.3
|
1.5
|
1.0
|
OE1
|
A:GLN185
|
4.4
|
1.5
|
1.0
|
OD2
|
A:ASP182
|
4.4
|
1.5
|
1.0
|
OG1
|
A:THR105
|
4.4
|
5.5
|
1.0
|
N
|
A:ASP183
|
4.5
|
4.3
|
1.0
|
N
|
A:GLU184
|
4.5
|
4.2
|
1.0
|
CA
|
A:GLU184
|
4.6
|
1.7
|
1.0
|
CA
|
A:ASP183
|
4.6
|
5.2
|
1.0
|
C
|
A:ASP183
|
4.7
|
5.4
|
1.0
|
CD1
|
A:TRP186
|
4.7
|
1.5
|
1.0
|
N
|
A:TRP186
|
4.9
|
4.3
|
1.0
|
CD
|
A:GLN185
|
5.0
|
1.5
|
1.0
|
|
Calcium binding site 3 out
of 6 in 1biw
Go back to
Calcium Binding Sites List in 1biw
Calcium binding site 3 out
of 6 in the Design and Synthesis of Conformationally-Constrained Mmp Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca305
b:5.7
occ:1.00
|
O
|
A:ASN175
|
2.2
|
2.0
|
1.0
|
O
|
A:ASP141
|
2.3
|
3.7
|
1.0
|
OD1
|
A:ASP177
|
2.3
|
6.5
|
1.0
|
O
|
A:GLY173
|
2.3
|
1.5
|
1.0
|
O
|
A:HOH326
|
2.4
|
1.5
|
1.0
|
O
|
A:HOH314
|
2.6
|
14.7
|
1.0
|
CG
|
A:ASP177
|
3.2
|
1.6
|
1.0
|
OD2
|
A:ASP177
|
3.3
|
1.5
|
1.0
|
C
|
A:ASP141
|
3.4
|
3.9
|
1.0
|
C
|
A:ASN175
|
3.4
|
1.5
|
1.0
|
C
|
A:GLY173
|
3.5
|
2.3
|
1.0
|
O
|
A:ALA140
|
3.9
|
6.4
|
1.0
|
CA
|
A:ASP141
|
4.2
|
5.2
|
1.0
|
C
|
A:ILE174
|
4.2
|
4.7
|
1.0
|
O
|
A:GLY171
|
4.2
|
13.8
|
1.0
|
N
|
A:ASN175
|
4.2
|
1.8
|
1.0
|
CA
|
A:GLY176
|
4.2
|
2.1
|
1.0
|
N
|
A:GLY173
|
4.3
|
11.8
|
1.0
|
N
|
A:GLY176
|
4.3
|
1.5
|
1.0
|
N
|
A:ASP177
|
4.3
|
1.8
|
1.0
|
CA
|
A:ASN175
|
4.4
|
1.5
|
1.0
|
O
|
A:ILE174
|
4.4
|
5.8
|
1.0
|
CA
|
A:GLY173
|
4.4
|
3.7
|
1.0
|
C
|
A:GLY176
|
4.4
|
1.5
|
1.0
|
N
|
A:ILE142
|
4.5
|
5.1
|
1.0
|
N
|
A:ILE174
|
4.5
|
3.5
|
1.0
|
CB
|
A:ASP177
|
4.5
|
1.5
|
1.0
|
CA
|
A:ILE174
|
4.5
|
6.0
|
1.0
|
C
|
A:PRO172
|
4.6
|
14.6
|
1.0
|
N
|
A:MET143
|
4.7
|
4.9
|
1.0
|
CH2
|
A:TRP92
|
4.7
|
2.4
|
1.0
|
CA
|
A:ILE142
|
4.7
|
3.0
|
1.0
|
CG
|
A:MET143
|
4.9
|
1.5
|
1.0
|
CA
|
A:ASP177
|
4.9
|
1.5
|
1.0
|
C
|
A:ALA140
|
4.9
|
7.4
|
1.0
|
O
|
A:PRO172
|
4.9
|
17.6
|
1.0
|
|
Calcium binding site 4 out
of 6 in 1biw
Go back to
Calcium Binding Sites List in 1biw
Calcium binding site 4 out
of 6 in the Design and Synthesis of Conformationally-Constrained Mmp Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca803
b:5.2
occ:1.00
|
OE2
|
B:GLU184
|
2.3
|
1.5
|
1.0
|
OD2
|
B:ASP181
|
2.3
|
1.5
|
1.0
|
O
|
B:VAL163
|
2.3
|
5.9
|
1.0
|
O
|
B:ASP158
|
2.3
|
23.4
|
1.0
|
O
|
B:GLY159
|
2.3
|
14.1
|
1.0
|
O
|
B:GLY161
|
2.4
|
6.4
|
1.0
|
OD1
|
B:ASP158
|
2.4
|
1.5
|
1.0
|
CG
|
B:ASP181
|
3.3
|
4.8
|
1.0
|
C
|
B:ASP158
|
3.4
|
18.5
|
1.0
|
C
|
B:VAL163
|
3.5
|
5.6
|
1.0
|
CD
|
B:GLU184
|
3.5
|
4.3
|
1.0
|
C
|
B:GLY159
|
3.5
|
12.7
|
1.0
|
C
|
B:GLY161
|
3.5
|
3.5
|
1.0
|
CG
|
B:ASP158
|
3.6
|
1.5
|
1.0
|
N
|
B:GLY161
|
3.9
|
7.9
|
1.0
|
N
|
B:VAL163
|
4.1
|
5.3
|
1.0
|
OD1
|
B:ASP181
|
4.1
|
4.5
|
1.0
|
CB
|
B:ASP181
|
4.1
|
2.6
|
1.0
|
CA
|
B:GLY159
|
4.2
|
14.0
|
1.0
|
CA
|
B:VAL163
|
4.3
|
7.0
|
1.0
|
OE1
|
B:GLU184
|
4.3
|
5.8
|
1.0
|
CA
|
B:GLY161
|
4.3
|
2.4
|
1.0
|
N
|
B:GLY159
|
4.3
|
17.6
|
1.0
|
CA
|
B:ASP158
|
4.3
|
13.2
|
1.0
|
N
|
B:ASP158
|
4.4
|
14.2
|
1.0
|
CB
|
B:ASP158
|
4.4
|
6.5
|
1.0
|
CG
|
B:GLU184
|
4.4
|
1.5
|
1.0
|
C
|
B:PRO160
|
4.4
|
12.0
|
1.0
|
OD2
|
B:ASP158
|
4.5
|
3.2
|
1.0
|
N
|
B:LEU164
|
4.5
|
2.2
|
1.0
|
N
|
B:PRO160
|
4.6
|
10.5
|
1.0
|
C
|
B:ASN162
|
4.6
|
4.5
|
1.0
|
N
|
B:ASN162
|
4.6
|
3.5
|
1.0
|
CA
|
B:LEU164
|
4.7
|
1.5
|
1.0
|
CA
|
B:PRO160
|
4.7
|
11.0
|
1.0
|
CA
|
B:ASN162
|
4.9
|
5.2
|
1.0
|
O
|
B:HOH822
|
4.9
|
1.5
|
1.0
|
CB
|
B:VAL163
|
5.0
|
9.1
|
1.0
|
|
Calcium binding site 5 out
of 6 in 1biw
Go back to
Calcium Binding Sites List in 1biw
Calcium binding site 5 out
of 6 in the Design and Synthesis of Conformationally-Constrained Mmp Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 5 of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca804
b:15.1
occ:1.00
|
OD2
|
B:ASP107
|
2.3
|
3.0
|
1.0
|
O
|
B:ASP182
|
2.3
|
7.5
|
1.0
|
OD1
|
B:ASP182
|
2.3
|
3.6
|
1.0
|
OD1
|
B:ASP107
|
2.3
|
1.5
|
1.0
|
O
|
B:GLU184
|
2.4
|
2.1
|
1.0
|
O
|
B:HOH823
|
2.5
|
18.6
|
1.0
|
CG
|
B:ASP107
|
2.7
|
2.8
|
1.0
|
C
|
B:ASP182
|
3.4
|
7.2
|
1.0
|
CG
|
B:ASP182
|
3.4
|
1.5
|
1.0
|
C
|
B:GLU184
|
3.6
|
2.7
|
1.0
|
CA
|
B:ASP182
|
4.0
|
3.4
|
1.0
|
CB
|
B:ASP182
|
4.1
|
4.4
|
1.0
|
OG1
|
B:THR105
|
4.2
|
6.9
|
1.0
|
CB
|
B:ASP107
|
4.2
|
3.2
|
1.0
|
CA
|
B:GLN185
|
4.3
|
1.7
|
1.0
|
OD2
|
B:ASP182
|
4.3
|
1.5
|
1.0
|
CD1
|
B:TRP186
|
4.4
|
1.8
|
1.0
|
N
|
B:GLN185
|
4.4
|
1.7
|
1.0
|
N
|
B:ASP183
|
4.5
|
7.9
|
1.0
|
N
|
B:GLU184
|
4.6
|
2.6
|
1.0
|
N
|
B:TRP186
|
4.7
|
2.1
|
1.0
|
CA
|
B:GLU184
|
4.7
|
4.2
|
1.0
|
C
|
B:ASP183
|
4.7
|
3.7
|
1.0
|
CA
|
B:ASP183
|
4.8
|
4.9
|
1.0
|
NE1
|
B:TRP186
|
4.9
|
1.5
|
1.0
|
O
|
B:HOH818
|
4.9
|
22.4
|
1.0
|
OE1
|
B:GLN185
|
4.9
|
25.4
|
1.0
|
N
|
B:ASP107
|
5.0
|
5.2
|
1.0
|
|
Calcium binding site 6 out
of 6 in 1biw
Go back to
Calcium Binding Sites List in 1biw
Calcium binding site 6 out
of 6 in the Design and Synthesis of Conformationally-Constrained Mmp Inhibitors
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 6 of Design and Synthesis of Conformationally-Constrained Mmp Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca805
b:2.0
occ:1.00
|
OD1
|
B:ASP177
|
2.2
|
12.2
|
1.0
|
O
|
B:GLY173
|
2.3
|
3.1
|
1.0
|
O
|
B:ASN175
|
2.3
|
6.4
|
1.0
|
O
|
B:ASP141
|
2.3
|
1.5
|
1.0
|
O
|
B:HOH819
|
2.4
|
29.8
|
1.0
|
O
|
B:HOH807
|
2.5
|
1.5
|
1.0
|
CG
|
B:ASP177
|
3.0
|
7.9
|
1.0
|
OD2
|
B:ASP177
|
3.1
|
9.6
|
1.0
|
C
|
B:ASP141
|
3.4
|
3.2
|
1.0
|
C
|
B:GLY173
|
3.5
|
2.1
|
1.0
|
C
|
B:ASN175
|
3.5
|
5.2
|
1.0
|
O
|
B:ALA140
|
3.7
|
5.6
|
1.0
|
CA
|
B:GLY176
|
4.2
|
1.8
|
1.0
|
CA
|
B:ASP141
|
4.2
|
1.5
|
1.0
|
N
|
B:ASP177
|
4.3
|
3.3
|
1.0
|
N
|
B:GLY173
|
4.3
|
3.6
|
1.0
|
CA
|
B:GLY173
|
4.3
|
1.5
|
1.0
|
CB
|
B:ASP177
|
4.3
|
2.4
|
1.0
|
C
|
B:ILE174
|
4.3
|
6.4
|
1.0
|
N
|
B:GLY176
|
4.3
|
2.4
|
1.0
|
N
|
B:ASN175
|
4.3
|
4.8
|
1.0
|
C
|
B:GLY176
|
4.4
|
1.5
|
1.0
|
O
|
B:GLY171
|
4.4
|
1.5
|
1.0
|
N
|
B:ILE142
|
4.4
|
6.6
|
1.0
|
N
|
B:ILE174
|
4.5
|
6.6
|
1.0
|
O
|
B:ILE174
|
4.5
|
4.8
|
1.0
|
CA
|
B:ASN175
|
4.5
|
5.6
|
1.0
|
N
|
B:MET143
|
4.6
|
4.2
|
1.0
|
CA
|
B:ILE174
|
4.6
|
5.4
|
1.0
|
C
|
B:PRO172
|
4.7
|
4.3
|
1.0
|
C
|
B:ALA140
|
4.7
|
5.2
|
1.0
|
CG
|
B:MET143
|
4.7
|
4.0
|
1.0
|
CA
|
B:ILE142
|
4.7
|
3.2
|
1.0
|
CA
|
B:ASP177
|
4.7
|
1.5
|
1.0
|
O
|
B:PRO172
|
4.9
|
1.5
|
1.0
|
|
Reference:
M.G.Natchus,
M.Cheng,
C.T.Wahl,
S.Pikul,
N.G.Almstead,
R.S.Bradley,
Y.O.Taiwo,
G.E.Mieling,
C.M.Dunaway,
C.E.Snider,
J.M.Mciver,
B.L.Barnett,
S.J.Mcphail,
M.B.Anastasio,
B.De.
Design and Synthesis of Conformationally-Constrained Mmp Inhibitors. Bioorg.Med.Chem.Lett. V. 8 2077 1998.
ISSN: ISSN 0960-894X
PubMed: 9873489
DOI: 10.1016/S0960-894X(98)00370-9
Page generated: Thu Jul 11 06:25:52 2024
|